Clinical Trial Update: Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for EDG-5506 in Becker muscular dystrophy; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Becker Muscular Dystrophy

Drugs mentioned

• EDG-5506 (EDG-5506)

Snippet

Sponsor: Edgewise Therapeutics, Inc. | Conditions: Becker Muscular Dystrophy | Phase 2 | Status: ACTIVE_NOT_RECRUITING